AI New Drug Research Institute invites global scholars to give special lectures on AI-based autonomous laboratories
Oct 31, 2025
The AI New Drug Research Institute of the Korea Pharmaceutical Bio Association will hold a 'Global SDL Master Lecture'.
This special lecture was organized as part of the 'education and promotion of new drug development using artificial intelligence (AI)' project by the Ministry of Health and Welfare and the Korea Health Industry Promotion Agency.
The event, which will be held at the COEX Conference Room in Seoul from 1 p.m. to 4 p.m. on November 7, will invite Jason Hein, a world-renowned scholar of the University of British Columbia (UBC) in the field of the Self-Driving Lab (SDL). Professor Hain is a leading researcher in chemical reaction automation and SDL technology, leading the innovation of autonomous experiments in the field of global pharmaceutical R&D.
Professor Ha-in will give a lecture on the day on the subject of 'Experimental Automation to SDL: Innovative Transformation of Chemical R&D in Pharmaceutical Sector'▲Pharmaceutical R&D Challenges and the Need for SDL ▲ Evolution of Chemical Automation and SDL Concept ▲ Automation Cases ▲ Technological Foundation and Latest Applications of SDL 1.0 and 2.0 ▲ Future Prospects (SDL Network, Regulatory Linkage, Industry Application) and more.
This special lecture will be held simultaneously on-site and online for 150 workers in related fields such as AI, pharmaceutical, bio, and chemical. Participants will learn global-level AI experiment automation trends through real-world industrial applications along with the current status of global SDL research.
With this special lecture, the AI Research Institute plans to strengthen global cooperation in SDL education and research and establish a global talent training system centered on industrial sites in connection with the first AI new drug development SDL practice infrastructure construction project in Korea. In addition, in November, 'SDL intensive theory education' and 'Pharmaceutical BioAI manufacturing and quality education' will be promoted in succession to complete the AI new drug development pre-cycle education platform that encompasses theory, practice, and manufacturing quality.
"This special lecture is a valuable opportunity for the world's leading SDL research experts and the domestic industry to interact directly with each other," said Han Sang-hee, president of the AI Research Institute. "We will create an ecosystem for developing new drugs based on autonomous AI experiments through SDL infrastructure and specialized education, and raise the innovation capacity of the pharmaceutical bio industry to international level."."
This special lecture was organized as part of the 'education and promotion of new drug development using artificial intelligence (AI)' project by the Ministry of Health and Welfare and the Korea Health Industry Promotion Agency.
The event, which will be held at the COEX Conference Room in Seoul from 1 p.m. to 4 p.m. on November 7, will invite Jason Hein, a world-renowned scholar of the University of British Columbia (UBC) in the field of the Self-Driving Lab (SDL). Professor Hain is a leading researcher in chemical reaction automation and SDL technology, leading the innovation of autonomous experiments in the field of global pharmaceutical R&D.
|
This special lecture will be held simultaneously on-site and online for 150 workers in related fields such as AI, pharmaceutical, bio, and chemical. Participants will learn global-level AI experiment automation trends through real-world industrial applications along with the current status of global SDL research.
With this special lecture, the AI Research Institute plans to strengthen global cooperation in SDL education and research and establish a global talent training system centered on industrial sites in connection with the first AI new drug development SDL practice infrastructure construction project in Korea. In addition, in November, 'SDL intensive theory education' and 'Pharmaceutical BioAI manufacturing and quality education' will be promoted in succession to complete the AI new drug development pre-cycle education platform that encompasses theory, practice, and manufacturing quality.
"This special lecture is a valuable opportunity for the world's leading SDL research experts and the domestic industry to interact directly with each other," said Han Sang-hee, president of the AI Research Institute. "We will create an ecosystem for developing new drugs based on autonomous AI experiments through SDL infrastructure and specialized education, and raise the innovation capacity of the pharmaceutical bio industry to international level."."
This article was translated by Naver AI translator.
